Form4insider filings, from the source

SEC Form 4 · accession 0001106578-26-000117

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Aug 10, 2026
Accepted (ET)
Aug 11, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Aug 10, 2026M9,500$135.42A333,943Iby Trust
Common StockF3,F2Aug 10, 2026S578$523.9474D333,365Iby Trust
Common StockF4,F2Aug 10, 2026S582$524.858D332,783Iby Trust
Common StockF5,F2Aug 10, 2026S120$525.7299D332,663Iby Trust
Common StockF6,F2Aug 10, 2026S722$527.3809D331,941Iby Trust
Common StockF7,F2Aug 10, 2026S731$528.3963D331,210Iby Trust
Common StockF8,F2Aug 10, 2026S1,050$529.2671D330,160Iby Trust
Common StockF9,F2Aug 10, 2026S3,027$530.2613D327,133Iby Trust
Common StockF10,F2Aug 10, 2026S640$531.1493D326,493Iby Trust
Common StockF11,F2Aug 10, 2026S459$532.2803D326,034Iby Trust
Common StockF12,F2Aug 10, 2026S391$533.2113D325,643Iby Trust
Common StockF13,F2Aug 10, 2026S286$535.2742D325,357Iby Trust
Common StockF14,F2Aug 10, 2026S514$536.2326D324,843Iby Trust
Common StockF15,F2Aug 10, 2026S186$537.9138D324,657Iby Trust
Common StockF16,F2Aug 10, 2026S214$538.8628D324,443Iby Trust
Common Stockholding———40,513D
Common Stockholding———166Iby Spouse
Common StockF17holding———249,108Iby Trust
Common StockF18holding———45,596Iby Trust
Common StockF19holding———8,902Iby Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF20$135.42Aug 10, 2026M9,500DMar 15, 2023Mar 15, 2027Common Stock9,500170,410I

Explanation of responses